Adagio Medical Inc.

NASDAQ: ADGM · Real-Time Price · USD
1.30
0.04 (2.77%)
At close: Aug 15, 2025, 2:59 PM

Adagio Medical Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022
Period Ending Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022
Net Income
-7.71M -57.37M -14.57M -6.46M -245.85K -2.22M -455.07K 381.51K 160.25K -6.03M
Depreciation & Amortization
271K 424K 54K 262K 330K 133K n/a n/a 124K 135K
Stock-Based Compensation
218K 421K 421K 111K 110K 113K n/a n/a 99K 96K
Other Working Capital
n/a 1.78M 3.3M -154K 1.63M n/a 930.45K n/a n/a n/a
Other Non-Cash Items
n/a 49.97M 4.83M -28K -365.89K -525.13K -504.6K -460.36K -1.13M 38K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Change in Working Capital
n/a 1.78M 729.95K -830K 100.05K 2.7M 930.45K -363.14K 757.57K -37K
Operating Cash Flow
-7.21M -7.11M -8.53M -6.95M -511.69K -43.62K -29.22K -441.99K -211.03K -5.76M
Capital Expenditures
-335K n/a -31K -175K -162K -20K 5.00 n/a -65K 18K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a -3.97M -158K 3.97M -420K -420K -140K 114.65M n/a
Investing Cash Flow
-335K n/a -4M -333K 3.97M -420K -420K -140K 114.65M 8K
Debt Repayment
n/a -542K -10K -428K 970K 470K 445K 540K 600K 9.5M
Common Stock Repurchased
n/a n/a 4.36M n/a -4.36M n/a n/a n/a -115.07M n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a -16.78M 10.99M 5.5M 12.96M n/a n/a n/a 117.49M 4K
Financial Cash Flow
n/a n/a 13.95M 5.07M -3.39M 470K 445K 540K -114.47M 9.5M
Net Cash Flow
-7.62M n/a -1.36M -2.04M 67.31K 6.38K -4.22K -41.99K -31.03K 3.65M
Free Cash Flow
-7.55M n/a -8.56M -7.12M -673.69K -63.62K -29.23K -441.99K -276.03K -5.74M